Announcing the

Journal of Parkinson's Disease

Sister publication of the Journal of Alzheimer’s Disease

A prestigious new journal for original research in basic science, translational research and clinical medicine in Parkinson’s disease

The Journal of Parkinson’s Disease is dedicated to providing an open forum for original research in basic science, translational research and clinical medicine that will expedite our fundamental understanding and improve treatment of Parkinson’s disease. The journal is international and multidisciplinary and aims to promote progress in the epidemiology, etiology, genetics, molecular correlates, pathogenesis, pharmacology, psychology, diagnosis and treatment of Parkinson’s disease. It publishes research reports, reviews, short communications and letters to the editor. It offers very rapid publication and an affordable open access option.

The inaugural issue is freely available here.

Journal of Alzheimer’s Disease subscribers have free access to the Journal of Parkinson’s Disease.

Editors-in-Chief

Patrik Brundin, MD, PhD
allenberg Neuroscience Center
Lund University, Lund, Sweden
Email: patrik.brundin@iospress.com

J. William Langston, MD
The Parkinson's Institute and Clinical Center
Sunnyvale, CA, USA
Email: bill.langston@iospress.com

Associate Editors
Bastiaan Bloem, The Netherlands
M. Angela Cenci, Sweden
Mark R. Cookson, USA
Dennis Dickson, USA
Robert Edwards, USA
Howard Federoff, USA
Glenda Halliday, Australia
Andres Lozano, Canada
Tamas Revesz, United Kingdom
Nick Wood, United Kingdom

Founding Editors from the Journal of Alzheimer’s Disease
George Perry, PhD
University of Texas at San Antonio, USA

Mark A. Smith, PhD†
Case Western Reserve University, USA

CALL FOR PAPERS
Submit manuscripts electronically via the msTracker online submission system at http://mstracker.com/submit1.php?jc=jpd